These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10144015)

  • 21. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 22. Start-up model patently flawed.
    Corbyn Z
    Nature; 2010 Jul; 466(7304):303. PubMed ID: 20631768
    [No Abstract]   [Full Text] [Related]  

  • 23. Churning things up.
    Grove A
    Fortune; 2003 Aug; 148(3):114-6, 118. PubMed ID: 12931387
    [No Abstract]   [Full Text] [Related]  

  • 24. Biomedical entrepreneurship should be the fourth mission of all healthcare organizations.
    Meyers AD
    MedGenMed; 2007 Feb; 9(1):33. PubMed ID: 17435639
    [No Abstract]   [Full Text] [Related]  

  • 25. The innovation process centre stage.
    Med Device Technol; 2005 Sep; 16(7):28-31. PubMed ID: 16259158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The critical path to medical innovation.
    Williams D
    Med Device Technol; 2004 Jun; 15(5):8-10. PubMed ID: 15285478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Germany is winning at turning its research to commercial application.
    Savage N
    Nature; 2019 Mar; 567(7749):S38-S40. PubMed ID: 30918378
    [No Abstract]   [Full Text] [Related]  

  • 28. Making the world safer.
    Farwell L
    Time; 2001 Nov; 158(23):80-3, 86-7. PubMed ID: 11817277
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolution of new business in health care.
    Weinberger S; Weeks W
    J Health Care Finance; 2004; 31(2):53-61. PubMed ID: 15839529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The German MedTech industry in 2007.
    Schmitt JM; Beeres M
    Med Device Technol; 2007; 18(7):56. PubMed ID: 18075138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. U2B: a new model for technology transfer.
    Gross CM
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE31-2. PubMed ID: 12874975
    [No Abstract]   [Full Text] [Related]  

  • 32. America's 100 fastest-growing companies.
    Teitelbaum RS
    Fortune; 1995 Apr; 131(7):74-6, 80, 84 passim. PubMed ID: 10144014
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 34. Forces impacting technology growth.
    Ronning PL
    Hosp Technol Ser; 1994 Oct; 13(13):9-11. PubMed ID: 10137965
    [No Abstract]   [Full Text] [Related]  

  • 35. Academic-industrial collaboration: the good, the bad, and the ugly.
    Martin JB
    Trans Am Clin Climatol Assoc; 2002; 113():227-39; discussion 239-40. PubMed ID: 12053712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-licensing as a business model.
    Schafer DP
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE36-9. PubMed ID: 12089585
    [No Abstract]   [Full Text] [Related]  

  • 37. The editor's corner: medical technology and competitiveness in the world market: reinventing the environment for innovation.
    George WW
    J Appl Biomater; 1995; 6(2):147-52. PubMed ID: 7640443
    [No Abstract]   [Full Text] [Related]  

  • 38. QIOS assist in the transfer to technology.
    Adler D
    Provider; 2006 May; 32(5):41-4. PubMed ID: 17042457
    [No Abstract]   [Full Text] [Related]  

  • 39. Private company profiles.
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
    [No Abstract]   [Full Text] [Related]  

  • 40. Technology transfer: a university perspective.
    Cravalho EG
    Med Instrum; 1985; 19(1):3-9. PubMed ID: 3990597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.